Risk Minimization Top Cause of Enforcement Letters for Ads: Expert
Drugmakers’ omissions or minimizations of product risks are the leading cause of FDA enforcement letters for advertising, accounting for 70 of the 120 letters sent to pharma companies since 2009, experts say.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.